Hepatitis C genotype 3 disease.

Hepatitis C genotype 3 disease.

Item
http://www.wikidata.org/entity/Q30244065
State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and ImmunizationManagement of chronic Hepatitis C at a primary health clinic in the high-burden context of Karachi, Pakistan.Genotype 3 Infection: The Last Stand of Hepatitis C Virus.NS5A inhibitors for the treatment of hepatitis C infection.Sofosbuvir/velpatasvir: a pangenotypic drug to simplify HCV therapy.Cost-effectiveness analysis of the use of daclatasvir + sofosbuvir + ribavirin (16 weeks and 12 weeks) vs sofosbuvir + ribavirin (16 weeks and 24 weeks) for the treatment of cirrhotic patients affected with hepatitis C virus genotype 3 in Italy.Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.Sofosbuvir and velpatasvir: a stellar option for patients with decompensated hepatitis C virus (HCV) cirrhosis.Optimization of direct anti-viral agent treatment schedule: Focus on HCV genotype 3.Hepatitis C virus genotype 3: clinical features, current and emerging viral inhibitors, future challenges
P2860

Hepatitis C genotype 3 disease.

Item
http://www.wikidata.org/entity/Q30244065
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Hepatitis C genotype 3 disease.
@ast
Hepatitis C genotype 3 disease.
@en
type
label
Hepatitis C genotype 3 disease.
@ast
Hepatitis C genotype 3 disease.
@en
prefLabel
Hepatitis C genotype 3 disease.
@ast
Hepatitis C genotype 3 disease.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P356
P1433
P1476
Hepatitis C genotype 3 disease
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698